VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $842,129 | -88.2% | 89,875 | -69.0% | 0.00% | -86.7% |
Q2 2023 | $7,122,433 | -9.4% | 290,356 | -14.0% | 0.02% | -11.8% |
Q1 2023 | $7,857,627 | +0.6% | 337,672 | +9.4% | 0.02% | -5.6% |
Q4 2022 | $7,812,514 | +14.9% | 308,673 | -12.5% | 0.02% | +5.9% |
Q3 2022 | $6,801,000 | +27.3% | 352,733 | +68.2% | 0.02% | +41.7% |
Q2 2022 | $5,341,000 | +89.5% | 209,709 | +91.4% | 0.01% | +140.0% |
Q1 2022 | $2,818,000 | +582.3% | 109,570 | +1053.6% | 0.01% | +400.0% |
Q3 2021 | $413,000 | -33.5% | 9,498 | -21.6% | 0.00% | 0.0% |
Q1 2021 | $621,000 | -16.1% | 12,111 | -43.8% | 0.00% | 0.0% |
Q3 2020 | $740,000 | – | 21,543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |